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Objective: The clinical significance of retrograde collateral arterial perfusion of abdominal aortic aneurysms after
endovascular repair (type II endoleak) has not been completely characterized. In this study a canine model was used to
analyze intra-aneurysmal pressure, thrombus histologic characteristics, endoleak patency, and radiographic appearance of
type II endoleaks originating from single and multiple aneurysm side branches.
Methods: Prosthetic aneurysms with an intraluminal solid-state strain-gauge pressure transducer were created in the
infrarenal aorta of 14 mongrel dogs. A single collateral side branch was reimplanted in 4 animals, multiple side branches
were reimplanted in 6 animals, and no side branches were reimplanted in 4 control animals. Intra-aneurysmal and
systemic pressure was measured for 60 to 90 days after creation of the type II endoleak. Endoleak patency and flow were
assessed with duplex ultrasound scanning and cine–magnetic resonance angiography. Histologic analysis of the intra-
aneurysmal thrombus was also performed.
Results: Stent-graft exclusion reduced intra-aneurysmal pressure significantly in all animals, as compared with systemic
pressure (P < .001). All intra-aneurysmal pressure values are indexed to the systemic pressure, and are represented as a
percentage of the simultaneously obtained systemic pressure, which has a value of 1.0. Type II endoleaks originating from
multiple side branches exhibited significantly increased intra-aneurysmal systolic pressure, mean pressure, and pulse
pressure, as compared with endoleaks derived from either a single side branch (systolic pressure: multiple, 0.70  0.28
vs single, 0.50  0.19; P < .001; mean pressure: multiple, 0.78  0.23 vs single, 0.59  0.22, P < .001; pulse pressure:
multiple, 0.41 0.25 vs single, 0.17 0.15, P< .001) or excluded control aneurysms that had no side branches and no
endoleak (systolic pressure, 0.17  0.09; mean pressure, 0.14  0.10; pulse pressure, 0.098  0.08; P < .001).
Cine–magnetic resonance angiograms and duplex ultrasound scans documented persistent patency of multiple branch
endoleaks up to the time of euthanasia. In contrast, single side branch endoleaks thrombosed within 3 days (P < .001).
Thrombus in the aneurysm sac in close proximity to the endoleak contained intact red blood cells and limited fibrin.
Thrombus distant from the endoleak demonstrated extensive fibrin deposition and degraded red blood cells.
Conclusion: The canine model may be used to reliably measure intra-aneurysmal pressure in the presence of patent and
thrombosed type II endoleaks. In this model 2 or more side branches are necessary to maintain persistent patency of type II
endoleaks. These endoleaks are associatedwith significantly elevated intra-aneurysmal pressure, that is, 70% to 80% of systemic
pressure. These results suggest that persistent type II endoleaks have clinical significance. (J Vasc Surg 2004;40:985-94.)
Clinical Relevance: Endoleaks originating from retrograde flow in the side branch vessels of the aneurysm generate
significant levels of intra-aneurysmal pressure, that is, 70% to 80% of systemic pressure. At least 2 patent side branch
vessels appear to be necessary to cause persistent patency of type II endoleak in the canine model. Further studies will be
necessary to enable more complete characterization of retrograde endoleaks and to extend these findings to allow clinical
application. However, these results suggest that persistently patent type II endoleaks are of clinical significance and may
require more intensive follow-up or intervention.Endovascular treatment of abdominal aortic aneurysm
(AAA) is predicated on exclusion of the aneurysm from the
arterial circulation.1 Exclusion eliminates arterial flow and
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Continued aneurysm perfusion after endovascular repair
has been reported in 14% to 29% of patients in clinical
trials.2-8 This continued arterial perfusion has been termed
“endoleak,” and may be broadly categorized as originating
from either a direct antegrade or retrograde collateral
source.9,10 Antegrade perfusion results in transmission of
systemic arterial pressure to the aneurysm sac and contin-
ued risk for aneurysm rupture. Antegrade endoleak there-
fore mandates repair at the time of initial diagnosis.
In contrast, endoleaks that originate from retrograde
flow through collateral vessels into aneurysm side branch
arteries and the aneurysm sac are of undetermined signifi-
cance.11-13 The pressure and force associated with retro-
grade perfusion of the aneurysm sac has been incompletely
characterized. The risk for continued aneurysm expansion
and for aneurysm rupture has not been definitively estab-
lished.14,15 Attempts to measure intra-aneurysmal pressure
resulting from retrograde perfusion of the aneurysm have
been hindered by the challenges of accessing an aneurysm
that has been excluded from antegrade flow and by limita-
tions of the accuracy of hydrostatic column pressure trans-
ducers in measuring pressure through semisolid material
such as the thrombus contained within aneurysms.16 Con-
sequently, definitive conclusions regarding the risks and
management of retrograde endoleaks have not been estab-
lished. In this study a canine model was developed to
evaluate continued aneurysm perfusion after endovascular
treatment that occurred through retrograde flow in collat-
eral aneurysm side branch vessels, type II endoleaks. Ret-
rograde endoleaks were characterized with regard to the
resultant intra-aneurysmal pressure generated, effect of the
number of feeding side branch vessels on intra-aneurysmal
pressure and endoleak patency, histologic characterization
of the intra-aneurysmal thrombus, and radiographic ap-
Fig 1. Intraoperative photograph of aneurysm creation. Lumbar
arteries (arrow) have been anastomosed to the posterior aspect of
the prosthetic aneurysm with a Carrel patch. Pressure transducer
cable can be seen exiting the anterior aspect of the aneurysm.pearance at magnetic resonance imaging (MRI).MATERIAL AND METHODS
Animals and implantation. Prosthetic aneurysms
were created in the infrarenal aorta of 14 mongrel dogs. All
animals were treated in accordance with the Guide for the
Care and Use of Laboratory Animals formulated by the
Institute of Laboratory Animal Resources, Commission on
Life Sciences.17 Animals weighed between 25 and 30 kg.
After induction of general anesthesia (induction, thiopental
8 mg/kg intravenously; maintenance, isoflourane 2%)
transabdominal exposure of the aorta was performed. Sys-
temic anticoagulation (unfractionated sodium heparin,
2000 units intravenously) was maintained throughout the
period of arterial clamping. The prosthetic aneurysm con-
taining the intraluminal pressure transducer was implanted
as an interposition graft in the infrarenal aorta (Fig 1). Care
must be taken to ensure that no damage is done to the
adjoining retroperitoneal structures, such as the ureters.
Use of male animals is advantageous to avert surgical com-
plexities related to the canine uterus. Collateral side branch
vessels were reimplanted onto the aneurysm with a Carrel
patch technique (Fig 2). Minimal handling of the lumbar
vessels is important, to minimize the risk for vasospasm or
intimal injury to the lumbar arteries. In 4 animals a single
lumbar artery was reimplanted onto the aneurysm. In 6
animals multiple side branch vessels were reimplanted. Of
these 6 animals, 4 animals had reimplantation of 2 paired
lumbar arteries, whereas in 2 animals the caudal mesenteric
artery was reimplanted in addition to 2 lumbar arteries. No
Fig 2. Schematic of retrograde (type II) endoleak creation. A,
Prosthetic aneurysm (AAA) is sewn as an interposition graft in the
infrarenal aorta. Paired lumbar arteries (arrows) are reimplanted
onto the aneurysm as a Carrel patch. Strain-gauge pressure trans-
ducer (T) enables intra-aneurysmal pressure determination. Pres-
sure transducer is 3mm in diameter and 1mmdeep.B,Retrograde
(type II) endoleak is created by deploying a stent graft (SG)
coaxially through the aneurysm to exclude it from antegrade
perfusion.side branch arteries were reimplanted in 4 animals; these
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from the pressure transducer was tunneled laterally through
the abdominal wall and tracked subcutaneously to exit the
skin on the posterior aspect of the neck. Addition of a
protective collar aids in enabling the transducer site to heal
and to prevent manipulation by the animal. A second
implantable pressure transducer was placed in the native
aorta proximal to the aneurysm, and tunneled along a
parallel course, exiting the skin in the neck adjacent to the
first transducer. Measurements from both transducers were
obtained simultaneously to enable comparison of intra-
aneurysmal pressure and systemic arterial pressure.
Pressure transducer and prosthetic aneurysm
creation. An implantable, solid-state, strain-gauge pres-
sure transducer (Konigsberg Instruments) was used for
chronic in vivo monitoring of intra-aneurysmal pressure
(Fig 3). The transducer is highly accurate in measuring
pressure in a wide range of physiologic applications, includ-
ing intracardiac, intracecal, and intravascular thrombus.
The transducer is used in conjunction with data recording
software, which is the proprietary property of Data Inte-
grated Scientific Systems. Continuous pressure monitoring
and storage were performed with the Data Integrated
Scientific Systems software. The accuracy of the transducer
has also been confirmed in various media in vitro, including
liquid, gelatinous, and solid environments.18,19 Calibration
of the transducer should be preformed before implantation
and after explantation. The pressure transducer was approx-
imated to the luminal surface of the prosthetic aneurysm.
Prosthetic aneurysms were created by balloon dilation of
an 8-mm polytetrafluoroethylene (PTFE) conduit (Im-
pra; Bard Corp). The PTFE material was not altered, and
no layers of the graft were removed before dilation with
the balloon. The final aneurysm diameter was 30 mm
(Fig 4).
Creation of retrograde (type II) endoleak. After
implantation of the aneurysm containing the pressure
transducer and side branch arteries, intra-aneurysmal pres-
sure determinations were made daily for 2 weeks. Exclusion
of the aneurysm sac from antegrade perfusion was then
performed. An impermeable endovascular stent graft con-
structed from PTFE supported throughout its entire length
by nitinol stents (Viabahn endoprosthesis, W. L. Gore; 8
mm in diameter  5 cm long, 2 prostheses per aneurysm
exclusion deployed in an overlapping fashion through a 9F
sheath) was implanted transarterially via femoral access.
Because of the small size of the canine femoral arteries
relative to the large introducers necessary for stent-graft
deployment, open surgical exposure of the femoral arteries
is necessary. Intraoperative angiography was performed
through the contralateral femoral artery. Puncture of the
femoral arteries should be performed before creation of the
arteriotomy to prevent subintimal dissection. Continued
patency and retrograde flow in the aneurysm side branch
arteries was confirmed on angiograms after stent-graft de-
ployment excluded the aneurysm from antegrade arterial
flow. After stent-graft deployment intra-aneurysmal pres-
sure was determined continuously for 4 hours, then dailyfor 60 to 90 days, until euthanasia of the animal (mean, 71
days after type II endoleak creation). Most animals were
euthanized 60 days after type II endoleak creation; how-
ever, observations of 2 animals with multiple side branches
were continued for 90 days. No alterations in endoleak
patency or intra-aneurysmal pressure occurred during the
additional 30 days of observation.
Systemic pressure was obtained simultaneously with
the second transducer, which was implanted in the native
aorta. Intra-aneurysmal pressure was indexed to systemic
arterial pressure, and is reported as a percentage of systemic
pressure. In addition, systemic pressuremeasurements were
confirmed with a forelimb sphygmomanometer at the same
setting. Correlation of the sphygmomanometer with intra-
arterial pressure was highly accurate. Clopidogrel (75
mg/d) was administered to all animals after deployment of
the endovascular stent graft, to enhance retrograde en-
doleak patency.
Radiologic imaging. Radiologic evaluation was used
to assess patency of the reimplanted aneurysm side
branches and endoleak. At endografting, arteriography was
performed to demonstrate patency and direction of flow in
the aneurysm side branch arteries (lumbar, caudal mesen-
teric). At euthanasia selective canulation of the side branch
arteries was performed and selective arteriography was car-
ried out to evaluate retrograde endoleak patency and to
characterize the direction of flow in the side branch vessels
Fig 3. Implantable strain gauge pressure transducer. Tip of pres-
sure transducer is attached to the luminal surface of the aneurysm.and aneurysm sac.
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formed after initial creation of the aneurysm, using cine
sequences (Fig 5). High-field 3-dimensional MRIs and
electrocardiogram-gated cine-MRA images were obtained
with a 3.0-T system (GE Medical Systems). Images were
obtained in the coronal, axial, and sagittal planes, and were
used to plan subsequent imaging in the axial plane for
cine-gating MRA. Fast cine-echo sequences were used
before and after exclusion to study the patency of the
lumbar vessels and to characterize the intra-aneurysmal
thrombus. Gadodiamide (20 mL; Amersham Health) was
injected, followed by 10mL of normal saline solution flush,
with the injection timed to terminate at the beginning of
image acquisition. Initial images were obtained with cardi-
ac-gated, gradient-echo acquisition fast-spoiled gradient-
recalled acquisition protocol. Induction of general anesthe-
sia is necessary to control the animal’s respirations and to
prevent movement artifact.
Cine-MRA was performed again at 2, 4, and 6 weeks
after aneurysm exclusion with stent-graft deployment, to
assess the type II endoleak. Patency of the side branch
arteries with persistent retrograde perfusion of the aneu-
rysm sac was again studied. Duplex ultrasound scanning of
arterial flow in the aneurysm sac and in the side branch
Fig 4. Prosthetic aneurysm with implanted pressure transducer.
Transducer cable is tunneled laterally through the abdominal wall
and tracked subcutaneously to exit the skin on the posterior aspect
of the neck.arteries was performed intraoperatively before and afterantegrade exclusion. In animals with single side branch
endoleaks, duplex scanning was repeated 1, 2, and 3 days
after creation of the type II endoleak. Duplex ultrasound
scanning was performed at euthanasia to again assess side
branch patency and retrograde aneurysm perfusion.
Histologic and pathologic analysis. The AAA, in-
cluding the side branch arteries and the stent graft, was
perfusion-fixed at 100 mm Hg in 3% glutaraldehyde
buffered to pH 7.4 with sodium cacodylate. At euthana-
sia the aorta was clamped proximally and distally to the
aneurysm. The aneurysm and side branch vessels were
then removed en bloc for gross and microscopic patho-
logic analysis. The aneurysms were sectioned longitudi-
nally, and the stent graft was removed. After dehydration
in increasing concentrations of ethyl alcohol, represen-
tative sections were imbedded in paraffin. Longitudinal,
transverse, and oblique sectioning was performed, and
microscopic analysis was carried out with hematoxylin-
eosin stain. The stent graft was removed before section-
ing, because the microtome blade could not cut the
nitinol wire. Histologic interpretation was conducted
independently by a pathologist (R.G.) blinded to the
Fig 5. Three-dimensional reconstruction magnetic resonance
image with gadolinium enhancement. Paired lumbar arteries (ar-
row) are reimplanted onto the aneurysm sac (AAA). The inferior
vena cava is also visualized.origin of the histologic section.
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A, Before deployment of the stent graft, arterial flow enters the reimplanted lumbar arteries (black arrow) from the
aneurysm sac in an antegrade fashion. Strain-gauge pressure transducer (white arrow) can be seen exiting the aneurysm
laterally. B, After stent-graft deployment the aneurysm is excluded from antegrade arterial perfusion. C, Angiographic
image obtained after 8-second delay demonstrates retrograde opacification of the reimplanted lumbar artery (arrow)
leading to retrograde aneurysm perfusion (type II endoleak).
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measurements were indexed to the systemic pressure,
which was obtained simultaneously. All pressures are rep-
resented as a percentage of the systemic pressure, with the
systemic pressure having a value of 1.0. Continuous vari-
ables were analyzed with the Student t test. Discrete vari-
ables were analyzed with 2 analysis. Statistical significance
was assumed at P  .05.
RESULTS
Endoleak patency and flow assessment. Aneurysm
side branch patency and retrograde endoleak patency were
confirmed on intraoperative angiograms in all animals at
the time of exclusion of the aneurysm from antegrade flow
by stent-graft deployment (Fig 6). In all animals complete
exclusion from antegrade perfusion was achieved, and
therefore no type I endoleaks were present. Animals with
multiple aneurysm side branches (2 lumbar, with or with-
out caudal mesenteric arteries) demonstrated persistent
side branch and endoleak patency throughout the study.
Retrograde endoleak patency was confirmed with cine-
MRA (Fig 7) and duplex ultrasound scanning in animals
with aneurysms with multiple side branches. Angiography
performed by selective cannulation of the caudal mesen-
teric artery at euthanasia demonstrated retrograde flow in
the caudal mesenteric artery. This arterial flow resulted in
retrograde perfusion of the aneurysm sac, with contrast
pooling external to the stent graft. Arterial flow exited the
aneurysm sac through the paired lumbar arteries. This
finding was confirmed at cine-MRA in this animal. There-
fore patency was maintained, with flow entering the aneu-
rysm sac through retrograde flow in the caudal mesenteric
artery and emptying through to the lumbar artery.
In contrast, animals with aneurysms containing a single
side branch demonstrated thrombosis of the endoleak that
occurred within 3 days (mean, 2.3 days) of type II endoleak
Fig 7. Magnetic resonance image with gadolinium enhancement
of retrograde (type II) endoleak. Paired lumbar arteries (arrow) are
visualized perfusing the aneurysm sac in a retrograde manner.
Stent graft (SG) is seen within the aneurysm sac. Inferior vena cava
(IVC) is also visualized.creation. Arterial flow in the side branch and retrogradeaneurysm perfusion were confirmed absent at cine-MRA
and duplex ultrasound scanning. This difference in side
branch and endoleak patency was statistically significant (P
 .001).
Intra-aneurysmal pressure. After the stent graft was
deployed and antegrade perfusion of the aneurysm was elim-
inated, intra-aneurysmal pressure was significantly reduced
within 3 hours in all animals (P  .001; Table). After the
initial decline in intra-aneurysmal pressure, pressure measure-
Fig 8. Photomicrograph of lumbar artery and anastomosis to
prosthetic aneurysm. A, At low-power magnification viable endo-
thelial cells (arrow) are lining the lumen (L) of the patent lumbar
artery (hematoxylin-eosin stain; original magnification 40). B,
At higher magnification, anatomy of endothelial cells (arrow) is
more readily seen. Minimal intimal hyperplasia (IH) is present at
the anastomosis to the aneurysm.ments remained stable throughout the study (60-90 days). All
re ind
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dard deviation for the entire post-exclusion period. In aneu-
rysms with multiple side branches the systolic pressure within
the aneurysm sac after antegrade exclusion was 0.702 
0.283, versus 1.0 for systemic pressure (P .001). Similarly,
mean intra-aneurymal pressure after antegrade exclusion for
multiple side branch aneurysms was reduced to 0.784 
0.229, compared with 1.0 for systemic pressure (P  .001).
Pulse pressure within the multiple side branch aneurysms was
most significantly reduced by exclusion from antegrade per-
fusion (0.406  0.248 vs 1.0; P  .001). There was no
difference in intra-aneurysmal pressure between endoleaks
originating from 2 as compared with 3 side branches (systolic
pressure: 2 branches, 0.705 0.285 vs 3 branches, 0.701
0.302, PNS; mean pressure: 2 branches, 0.804 0.241 vs
3 branches, 0.797 0.223, PNS).
Aneurysms with type II endoleaks that originated from a
single side branch exhibited a greater reduction in intra-
aneurysmal pressure. The reduction in intra-aneurysmal pres-
sure began intraoperatively at endovascular stent-graft deploy-
ment. Intra-aneurysmal pressure reached stable levels within 3
hours of exclusion from antegrade perfusion. This reduction
in intra-aneurysmal pressure was significantly lower than the
pressure observed in aneurysms with multiple side branches
contributing to retrograde endoleak. The indexed systolic
intra-aneurysmal pressure for single side branch endoleakswas
0.502 0.19, versus 0.702 0.283 for multiple side branch
endoleaks (P  .001). Similarly, the reduction in mean
intra-aneurysmal pressure (single, 0.593  0.215 vs
multiple, 0.784  0.229; P  .001) and intra-aneurys-
mal pulse pressure (single, 0.168  0.154 vs multiple,
0.406  0.248; P  .001) was significantly greater for
aneurysms with a single side branch as compared to those
with multiple side branches contributing to retrograde
endoleak. Intra-aneurysmal pressure declined again after
endoleak thrombosis, which occurred at a mean of 2.3
days after endoleak creation. After thrombosis intra-
aneurysmal pressure was indistinguishable from that ob-
served in control aneurysms. Control animals with aneu-
rysms that had no side branches or endoleaks exhibited
the lowest intra-aneurysmal pressure after exclusion from
antegrade perfusion (systolic pressure, 0.172  0.091;
mean pressure, 0.137  0.102; pulse pressure, 0.098 
0.077).
Pathologic and qualitative histologic analysis.





Control (no branch) 0.17
Systemic pressure
P (single vs multiple aneurysm side branches) 
*All pressures listed were measured after creation of type II endoleak, and aGross pathologic analysis confirmed patency of the sidebranch vessels and the endoleak channel in aneurysms with
retrograde endoleaks originating from multiple side
branches. Occlusion of the side branch vessel in aneurysms
with a single side branch was also confirmed at gross
pathologic analysis. Microscopic analysis of the lumbar
arteries causing multiple side branch type II endoleaks
demonstrated a widely patent lumen lined by viable endo-
thelial cells (Fig 8).Minimal intimal hyperplasia was present
at the site of anastomosis to the aneurysm.
Significant variation in thrombus consistency was ob-
served within the aneurysm sac in animals with multiple
side branch retrograde endoleaks. In regions of the aneu-
rysm sac distant from the retrograde endoleak and patent
lumbar and caudal mesenteric arteries, greater thrombus
density with extensive fibrin deposition and degraded red
blood cells was observed (Fig 9). These findings were
suggestive of stable thrombus, with deposition occurring
significantly earlier. In contrast, regions of the aneurysm sac
in close proximity to the patent side branch arteries had
thrombus that contained intact red blood cells and limited
fibrin. Active remodeling with recent thrombus deposition
in close proximity to the patent side branches was sug-
gested by these findings.
DISCUSSION
Use of animal models to study endovascular treatment
of AAA preceded the initial reports of successful clinical
use.1 Initial animal studies evaluated the feasibility of stent-
graft implantation and endovascular aneurysm repair.20-22
Subsequently animal models have been used in a range of
experiments designed to provide further objective scientific
assessment of endovascular treatment of AAA.23-32 The
results of these laboratory studies influenced the clinical
management of patients with AAA with stent grafts. How-
ever, these studies have been limited in evaluating the
effects of retrograde collateral perfusion of the aneurysm
sac after treatment with a stent graft.1 The current model
allows for creation of a retrograde (type II) endoleak in a
model with continuous intra-aneurysmal and systemic pres-
sure measurement. In addition, the effects of retrograde
flow on intra-aneurysmal pressure, as well as the radio-
graphic appearance and histologic characterization of the
intra-aneurysmal thrombus is characterized. This combina-
tion of analyses makes the current model unique among
animal models. Animal experiments have provided evi-
rysm side branch arteries contributing to retrograde
sure* Mean pressure* Pulse pressure*
.28 0.78  0.23 0.41  0.25
.19 0.59  0.22 0.17  0.15
.09 0.14  0.10 0.098  0.08
1.0 1.0
.001 .001






.001dence indicating that continued aneurysm perfusion that
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site (type I) or a graft junction site (type III), are associated
with systemic pressurization of the aneurysm sac and high
risk for aneurysm rupture.33 Ex vivo analyses of endoleaks
and aneurysm perfusion have also contributed significantly
to the understanding of the effect of endovascular repair of
AAA.34-36
Significant elements of endovascular repair of AAA
remain incompletely characterized in previous ex vivo and
animal model analyses, however. The effect of retrograde
perfusion of the aneurysm sac that occurs through collateral
aneurysm side branches such as the lumbar and inferior
mesenteric arteries after antegrade aneurysm exclusion is
principal among these. Studies of clinical assessment of
intrasac pressure have reported varied results. Direct cath-
eter access of the aneurysm sac has indicated that signifi-
cantly elevated pressures may result from continued retro-
grade perfusion after endovascular repair.12 Instances of
continued aneurysm expansion and even aneurysm rupture
resulting from retrograde endoleaks have also been report-
ed.14,15 However, in most cases reported, stabilization of
aneurysm size has been noted.37,38 In addition, the success
of treatments designed to thrombose type II endoleaks has
been variable.39 The potential for intermittent patency or
visualization of type II endoleaks has also been reported.40
The current study used a canine AAAmodel with a pressure
transducer implanted over a prolonged period to evaluate
the pressure generated within the aneurysm sac by type II
endoleaks. The transducer is constructed from solid-state
Fig 9. Photomicrograph of aneurysm content. In close proximity
to retrograde endoleak and patent side branch arteries the intra-
aneurysmal thrombus is comprised predominately of intact red
blood cells with limited fibrin deposition (L). In regions of the
aneurysm distant from the endoleak (arrow) greater thrombus
density, with extensive fibrin deposition and degraded red blood
cell fragments, is present.components, and uses a strain-gauge to monitor intra-aneurysmal pressure. The transducer has been evaluated in
a range of ex vivo and in vivo settings.18,19,29 It has dem-
onstrated a high degree of accuracy in liquid, semisolid, and
solid media, including flowing blood, thrombus, gelatin,
intramural cardiac tissue, and cecal contents. These features
contributed significantly to the ability to accurately assess
the intra-aneurysmal pressure in the presence of thrombus
in this study.
The effect of the number of aneurysm side branches on
endoleak patency was significant in the current study. Ani-
mals that had multiple side branch arteries demonstrated
continued patency of the type II endoleak throughout
follow-up, which ranged from 60 to 90 days. In contrast,
animals with a single arterial vessel supplying the retrograde
endoleak experienced rapid thrombosis of the endoleak,
within 3 days after endoleak creation. For endoleaks origi-
nating from multiple side branches, arterial flow was docu-
mented to enter the aneurysm sac through one vessel and to
exit the aneurysm sac through a second, distinct vessel. On
the basis of these findings, it appears that at least 2 side
branches are necessary to enable flow through the aneu-
rysm sac and to prevent thrombosis of the endoleak. These
findings may have implications for clinical management of
persistent type II endoleaks. If 2 or potentially more patent
side branches are necessary to enable flow through the
aneurysm sac, treatment success may be increased by iden-
tification of the inflow and outflow vessels. Cine-MRA was
valuable in confirming type II endoleak patency or throm-
bosis in the study animals. These findings may also provide
a rationale for inducing thrombosis within the aneurysm sac
in addition to the side branch vessels.
The pressure generated by retrograde aneurysmperfusion
varied according to the number of vessels contributing to the
endoleak. In aneurysmswith 2or 3 side branches contributing
to retrograde perfusion, intra-aneurysmal pressure was main-
tained at greater than 70% of systemic pressure. Of note, there
was no difference in the intra-aneurysmal pressure generated
by retrograde perfusion originating from 2, as compared with
3, side branch vessels. This level of intra-aneurysmal pressure
appears to be significant, although further studies will be
necessary to adequately characterize the clinical effects and
implications. In contrast to aneurysms with multiple side
branches, aneurysms with retrograde endoleaks that origi-
nated from a single side branch artery had significantly lower
intra-aneurysmal pressures, less than 60% of systemic pressure.
In addition, once thrombosis of the single side branch en-
doleak occurred, intra-aneurysmal pressure dropped to less
than 15% of systemic pressure. That pressure was equal to the
intra-aneurysmal pressure observed in the control animals,
with aneurysms with no side branches and no endoleaks. This
finding may suggest that the detection of persistent pressur-
ization of the aneurysm sac in patients without an obvious
endoleak may indicate an occult source of arterial perfusion
and that more aggressive attempts at localization could be
considered. Other sources of endotension, including hy-
groma and sac infection, should also be evaluated.
Characterization of the intra-aneurysmal thrombus in
animals with multiple arterial side branches and persistently
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that correlated with the location in the aneurysm sac. In
regions distant from the patent side branches and endoleak
the thrombus had greater density, with extensive fibrin
deposition. There were few intact red blood cells and
predominately red blood cell fragments. In contrast,
thrombus in close proximity to the endoleak and retro-
grade flow from the side branch arteries exhibited limited
fibrin deposition. The red blood cells were largely intact,
with few fragments, and the overall density was reduced.
These findings were paralleled by the results of MRI anal-
ysis, which demonstrated significant variability in the T1-
weighted and T2-weighted signal intensities. The variation
in MRI signal intensity corresponded to the differing his-
tologic appearance of the thrombus. These findings suggest
that thrombus deposition in the aneurysm remote from the
endoleak occurred early after stent-graft deployment ex-
cluded antegrade perfusion and that the remote thrombus
was relatively stable. In contrast, thrombus in close prox-
imity to the endoleak appeared to be recently deposited,
and may have been subject to ongoing remodeling, with
repeated cycles of resorption and deposition. Further long-
term studies will be necessary to further characterize the
relationship of endoleak chronicity and thrombus consis-
tency. It is important to note that significant differences
exist between the canine and human coagulation systems.
As a consequence of these differences, characterization of
thrombus formation must be tempered. In addition, data
from the study regarding endoleak patency must also be
viewed in light of these coagulation differences.
CONCLUSIONS
The canine model of AAA with a chronically implanted
intraluminal pressure transducer enables accurate pressure
determination in thrombus over extended periods of im-
plantation. Deployment of a stent graft to exclude the
aneurysm from antegrade arterial perfusion results in for-
mation of a retrograde endoleak (type II). Endoleaks orig-
inating from retrograde flow in the side branch vessels of
the aneurysm generate significant levels of intra-aneurysmal
pressure, that is, 70% to 80% of systemic pressure. At least 2
patent side branch vessels appear to be necessary to cause
persistent patency of the type II endoleak in the canine
model. Further studies will be necessary to enable more
complete characterization of retrograde endoleaks and to
extend these findings to allow clinical application.
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